64x Bio Funding: $55M Raised, Series A (2022)

64x Bio funding overview

64x Bio is based in San Francisco, CA. 64x Bio has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2022. The round record for 64x Bio runs through 2022; nothing later has been disclosed. Investors on record include Lifeforce Capital, Northpond Ventures, Michael Chambers, Future Ventures, First Round Capital, Chris Gibson and 5 others. 11 distinct backers are named across the disclosed rounds.

64x Bio at a glance

Total raised: $55M
Latest round: Series A
Latest round date: January 2022
Headquarters: San Francisco, CA
Notable investors: Lifeforce Capital, Northpond Ventures, Michael Chambers, Future Ventures, First Round Capital, Chris Gibson, Alix Ventures, Fifty Years

Frequently asked about 64x Bio funding

How much has 64x Bio raised?: 64x Bio has raised $55M in total disclosed funding across the rounds on record.
Who has invested in 64x Bio?: Lifeforce Capital, Northpond Ventures, Michael Chambers, Future Ventures, First Round Capital, Chris Gibson are named among the investors backing 64x Bio.
What was the latest 64x Bio funding round?: The most recent disclosed round is a Series A, announced in January 2022.
Where is 64x Bio based?: 64x Bio is based in San Francisco, CA.
When did 64x Bio last raise?: The last disclosed 64x Bio round closed in January 2022 at Series A.

Totals shown for 64x Bio aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.

64x Bio Funding: $55M Raised, Series A (2022)

64x Bio funding overview

64x Bio at a glance

Frequently asked about 64x Bio funding

Companies related to 64x Bio (20)

Browse related funding lists (9)